What is Faks?
Founded in 2020 and headquartered in Paris, Faks offers a secure, modular, and neutral communication platform designed to centralize interactions within the pharmaceutical ecosystem. The application serves over 17,000 pharmacies, 500 laboratories, and 130 pharmacy groups, streamlining critical operations such as expired medication management, claims processing, and trade campaigns. By facilitating enhanced collaboration, Faks aims to optimize workflows and business relationships for pharmacy professionals.
How much funding has Faks raised?
Faks has raised a total of $11.6M across 2 funding rounds:
Other Financing Round
$5.4M
Other Financing Round
$6.2M
Other Financing Round (2023): $5.4M with participation from Cocoa Ventures, Seedcamp, and Connect Ventures
Other Financing Round (2025): $6.2M led by Seedcamp, FJ Labs, Speedinvest, and Connect Ventures
Key Investors in Faks
Cocoa Ventures
Cocoa Ventures is an investment firm that provides capital and strategic support to promising companies. Their investment in Faks indicates a belief in the company's innovative approach to the pharmaceutical communication sector.
Seedcamp
Seedcamp is a venture capital firm that supports early-stage startups by providing investment, mentorship, and access to a global network. The firm focuses on ambitious founders and innovative companies across various sectors, helping them grow from initial concepts to successful businesses.
Connect Ventures
Connect Ventures is a venture firm based in London that focuses on investing in pre-seed and seed stage product companies. Established in 2012, it aims to provide support and capital to exceptional founders driving innovative change.
What's next for Faks?
The substantial capital infusion, particularly the recent strategic investment, positions Faks for accelerated growth and market penetration. This backing is likely to support the enhancement of its platform's capabilities, expansion into new markets, and strengthening of its user base. The company's focus on providing a neutral and secure communication channel within the highly regulated pharmaceutical industry suggests a strategic approach to scaling its operations and solidifying its position as a key enabler of digital transformation in the sector.
See full Faks company page
